These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
673 related items for PubMed ID: 22837345
1. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Camilleri M, Lasch K, Zhou W. Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G775-85. PubMed ID: 22837345 [Abstract] [Full Text] [Related]
2. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V. J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358 [Abstract] [Full Text] [Related]
3. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, Stanghellini V, Grundy D, Tonini M, De Ponti F, Corinaldesi R, Barbara G. Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712 [Abstract] [Full Text] [Related]
4. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Elsenbruch S. Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682 [Abstract] [Full Text] [Related]
5. Visceral hypersensitivity in irritable bowel syndrome. Kanazawa M, Hongo M, Fukudo S. J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723 [Abstract] [Full Text] [Related]
6. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation? Piche T. Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256 [Abstract] [Full Text] [Related]
7. [Progress in role of estrogens in visceral hypersensitivity of IBS]. Dong X, Chen SL. Sheng Li Ke Xue Jin Zhan; 2010 Oct; 41(5):362-4. PubMed ID: 21416927 [No Abstract] [Full Text] [Related]
8. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Keszthelyi D, Troost FJ, Masclee AA. Am J Physiol Gastrointest Liver Physiol; 2012 Jul 15; 303(2):G141-54. PubMed ID: 22595988 [Abstract] [Full Text] [Related]
9. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation? Keszthelyi D, Troost FJ, Jonkers DM, Helyes Z, Hamer HM, Ludidi S, Vanhoutvin S, Venema K, Dekker J, Szolcsányi J, Masclee AA. Eur J Pain; 2013 Oct 15; 17(9):1299-306. PubMed ID: 23529955 [Abstract] [Full Text] [Related]
10. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M. Gut; 2009 Feb 15; 58(2):196-201. PubMed ID: 18824556 [Abstract] [Full Text] [Related]
11. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Bertiaux-Vandaële N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, Leroi AM, Déchelotte P, Ménard JF, Ducrotté P, Coëffier M. Am J Gastroenterol; 2011 Dec 15; 106(12):2165-73. PubMed ID: 22008894 [Abstract] [Full Text] [Related]
12. Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome. Yu YB, Zuo XL, Zhao QJ, Chen FX, Yang J, Dong YY, Wang P, Li YQ. Gut; 2012 May 15; 61(5):685-94. PubMed ID: 21997550 [Abstract] [Full Text] [Related]
13. The pathophysiology of irritable bowel syndrome. Schwetz I, Bradesi S, Mayer EA. Minerva Med; 2004 Oct 15; 95(5):419-26. PubMed ID: 15467517 [Abstract] [Full Text] [Related]
14. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC. J Gastroenterol Hepatol; 2006 Jan 15; 21(1 Pt 1):71-8. PubMed ID: 16706815 [Abstract] [Full Text] [Related]
15. Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome. Verne GN, Sen A, Price DD. J Pain; 2005 Aug 15; 6(8):493-6. PubMed ID: 16084463 [Abstract] [Full Text] [Related]
16. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F, Santos J, Vicario M. Gut; 2013 Aug 15; 62(8):1160-8. PubMed ID: 22637702 [Abstract] [Full Text] [Related]
17. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Am J Gastroenterol; 2009 Feb 15; 104(2):392-400. PubMed ID: 19174797 [Abstract] [Full Text] [Related]
18. Mucosal barrier defects in irritable bowel syndrome. Who left the door open? Barbara G. Am J Gastroenterol; 2006 Jun 15; 101(6):1295-8. PubMed ID: 16771952 [Abstract] [Full Text] [Related]
20. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice. Du L, Long Y, Kim JJ, Chen B, Zhu Y, Dai N. Dig Dis Sci; 2019 Mar 15; 64(3):729-739. PubMed ID: 30446929 [Abstract] [Full Text] [Related] Page: [Next] [New Search]